Cargando…
Implementation of the OMERACT Psoriatic Arthritis Magnetic Resonance Imaging Scoring System in a randomized phase IIb study of abatacept in psoriatic arthritis
OBJECTIVES: To investigate if the OMERACT PsA MRI Scoring System (PsAMRIS), including a novel total inflammation score, shows sensitivity to change with an agent (abatacept) known to impact clinical outcomes in PsA. METHODS: We performed a post hoc analysis of a randomized phase IIb study of abatace...
Autores principales: | Østergaard, Mikkel, Bird, Paul, Pachai, Chahin, Du, Shuyan, Wu, Chun, Landis, Jessica, Fuerst, Thomas, Ahmad, Harris A, Connolly, Sean E, Conaghan, Philip G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9629349/ https://www.ncbi.nlm.nih.gov/pubmed/35137002 http://dx.doi.org/10.1093/rheumatology/keac073 |
Ejemplares similares
-
Abatacept in psoriatic arthritis: Case report and short review
por: Ursini, Francesco, et al.
Publicado: (2013) -
Current treatment options for psoriatic arthritis: spotlight on abatacept
por: Ursini, Francesco, et al.
Publicado: (2018) -
Abatacept for the treatment of adults with psoriatic arthritis: patient selection and perspectives
por: Noisette, Ashley, et al.
Publicado: (2018) -
Magnetic resonance imaging in psoriatic arthritis: a review of the literature
por: McQueen, Fiona, et al.
Publicado: (2006) -
Abatacept reduces synovial regulatory T-cell expression in patients with psoriatic arthritis
por: Szentpetery, Agnes, et al.
Publicado: (2017)